Login
$BRKR
$60.62 -$0.97 (1.57%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Frank H. Laukien Also a director
Chairman, President and Chief Executive Officer
66 Not stated Not stated $4,706,388
Gerald N. Herman
Executive Vice President and Chief Financial Officer
68 Not stated 2016 $2,010,308
Burkhard A. Prause
PRES. & CEO, BRUKER BEST
Title from the Form 4 dated Aug 15, 2026
59 Not stated Not stated Not reported
Thomas Bures
Chief Accounting Officer
Title from the Form 4 dated Aug 15, 2026
Not stated Not stated Not stated Not reported
Falko Busse
President, Bruker BioSpin Group
59 Since 2018
8 years
2015 Not reported
Mark R. Munch
President of Bruker NANO Group and Corporate Executive Vice President
64 Not stated Not stated Not reported
Juergen W. Srega
President, Bruker CALID Group and Bruker Daltonics Division
71 Not stated Not stated Not reported
Wolfgang Pusch
President BMID Group
Title from the Form 4 dated Aug 15, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
10 of 11
stated in the proxy
Average tenure
11.7 years
from year joined
CEO also chairs the board
Yes
Frank H. Laukien, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Frank H. Laukien, Ph.D.
66 1991
35 years
Not independent None stated None stated Paid as CEO
Richard A. Packer
68 2007
19 years
Independent
Nominating & Governance Committee
None stated $263,365
John J. (Jack) Phillips
60 2026
this year
Independent
Compensation Committee
None stated Not stated
Hermann F. Requardt, Ph.D.
71 2015
11 years
Independent
Compensation Committee
None stated Not stated
Laura A. Francis
59 2025
1 year
Independent
Audit Committee
None stated $243,349
Thierry L. Bernard
61 2026
this year
Independent None stated Neogen Corporation Not stated
William A. Linton, Ph.D.
78 2000
26 years
Independent
Nominating & Governance Committee
None stated Not stated
Adelene Q. Perkins
66 2017
9 years
Independent
Nominating & Governance Committee · Chair
None stated $252,032
Robert J. Rosenthal, Ph.D.
69 2015
11 years
Independent
Audit Committee Compensation Committee
Safeguard Scientifics, Inc. Not stated
Bonnie H. Anderson
68 2020
6 years
Independent
Compensation Committee · Chair Nominating & Governance Committee
None stated $258,449
John A. Ornell
68 2015
11 years
Independent
Audit Committee · Chair
None stated $272,532

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

9 disclosed in the proxy filed Apr 10, 2026
Dr. Dirk Laukien, Mr. Joerg Laukien and Ms. Laukien-Kleiner (co-owners of ZeroC Project GmbH)
half-brother, brother and stepmother of Dr. Frank H. Laukien
$292,896
2025

Bruker BioSpin AG rents a property in Faellanden, Switzerland from ZeroC Project GmbH under a lease agreement

With Bruker BioSpin AG Open in proxy
Promega Corporation
Dr. William A. Linton, a director of the Company, is Chairman, President, and Chief Executive Officer of Promega Corporation
Amount not stated
2025

Equipment sales to and purchases from Promega Corporation in the ordinary course of business

With the Company Open in proxy
Dr. Frank H. Laukien
EUR 2.8 million (approximately $3.1 million)
2025

Purchased 687,500 shares of Gauss Fusion GmbH from Bruker EAS GmbH, a wholly owned subsidiary of the Company

With Bruker EAS GmbH Open in proxy
Dr. Frank H. Laukien
EUR 2.7 million (approximately $3.1 million)
2025

Convertible loan agreement to Gauss Fusion GmbH

With Gauss Fusion GmbH Open in proxy
Two immediate family members of Dr. Frank H. Laukien
immediate family members of Dr. Frank H. Laukien
EUR 0.6 million (approximately $0.7 million)
2025

Collectively contributed additional funds to Gauss Fusion GmbH alongside Dr. Laukien's convertible loan

With Gauss Fusion GmbH Open in proxy
Asahi Kasei Corporation
Mr. Richard A. Packer, a director of the Company, is a Vice Presidential Executive Officer of Asahi Kasei Corporation
$155,383
2025

Equipment sales in the ordinary course of business to Asahi Kasei Corporation

With the Company Open in proxy
Dr. Meike Hamester
wife of Juergen Srega, the President of Bruker CALID Group
$235,148
2025

Employment with Bruker Daltonik GmbH as VP & Managing Director of Bruker Biosensors, with total compensation

With Bruker Daltonik GmbH Open in proxy
Dr. Venita Busse
wife of Falko Busse, the President of Bruker BioSpin Group
$237,112
2025

Employment with Bruker Switzerland AG as Director of Group Strategy Development, with total compensation

With Bruker Switzerland AG Open in proxy
Dr. Venita Busse
wife of Falko Busse, the President of Bruker BioSpin Group
Approximately $185,238
2026

Expected total compensation upon separation from the Company effective June 30, 2026

With Bruker Switzerland AG Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support